Abstract
Background In electronic health records, patterns of missing laboratory test results could capture patients’ course of disease as well as reflect clinician’s concerns or worries for possible conditions. These patterns are often understudied and overlooked. This study aims to characterize the patterns of missingness among laboratory data collected across 15 healthcare system sites in three countries for COVID-19 inpatients.
Methods We collected and analyzed demographic, diagnosis, and laboratory data for 69,939 patients with positive COVID-19 PCR tests across three countries from 1 January 2020 through 30 September 2021. We analyzed missing laboratory measurements across sites, missingness stratification by demographic variables, temporal trends of missingness, correlations between labs based on missingness indicators over time, and clustering of groups of labs based on their missingness/ordering pattern.
Results With these analyses, we identified mapping issues faced in seven out of 15 sites. We also identified nuances in data collection and variable definition for the various sites. Temporal trend analyses may support the use of laboratory test result missingness patterns in identifying severe COVID-19 patients. Lastly, using missingness patterns, we determined relationships between various labs that reflect clinical behaviors.
Conclusion This work elucidates how missing data patterns in EHRs can be leveraged to identify quality control issues and relationships between laboratory measurements. Missing data patterns will allow sites to attain better quality data for subsequent analyses and help researchers identify which sites are better poised to study particular questions. Our results could also provide insight into some of the biological relationships between labs in EHR data for COVID-19 patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
MM is supported by National Center for Advancing Translational Sciences (NCATS) UL1 TR001857. DAH is supported by NCATS UL1TR002240. WY is supported by National Institutes of Health (NIH) T32HD040128. BJA is supported by National Heart, Lung, and Blood Institute (NHLBI) U24 HL148865. WGL is supported by National Library of Medicine (NLM) R00LM012926. YL is supported by R01LM013337. SNM is supported by NCATS 5UL1TR001857-05 and National Human Genome Research Institute (NHGRI) 5R01HG009174-04. GSO is supported by NIH grants U24CA210967 and P30ES017885. LPP is supported by NCATS CTSA Award #UL1TR002366. SV is supported by NCATS UL1TR001857. GMW is supported by NCATS UL1TR002541, NCATS UL1TR000005, NLM R01LM013345, and NHGRI 3U01HG008685-05S2. ZX is supported by National Institute of Neurological Disorders and Stroke (NINDS) R01NS098023 and R01NS124882. QL is supported by National Institute of General Medical Sciences (NIGMS) R01GM124111 and NIH National Institute on Aging RF1AG063481. DLM is supported by NCATS UL1-TR001878. JHH is supported by NCATS UL1-TR001878.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review and Ethics Boards of all sites participating in the International Consortium for the Clinical Characterization of COVID-19 Using the Electronic Health Record (4CE) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
